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Abstract
Stroke and transient ischaemic attack (TIA) remain leading causes of mortality and morbidity
globally. Although mortality rates have been in decline, the number of people affected by stroke
has risen. These patients have a range of long-term needs and often present to primary care.
Furthermore, many of these patients have multimorbidities which increase the complexity of
their healthcare. Long-term impacts from stroke/TIA along with care needs for other morbid-
ities can be challenging to address because care can involve different healthcare professionals,
both specialist and generalist. In the ideal model of care, such professionals would work
collaboratively to provide care. Despite the commonality of multimorbidity in stroke/TIA, gaps
in the literature remain, particularly limited knowledge of pairings or clusters of comorbid
conditions and the extent to which these are interrelated. Moreover, integrated care practices
are less well understood and remain variable in practice. This article argues that it is important
to understand (through research) patterns of multimorbidity, including number, common
clusters and types of comorbidities, and current interprofessional practice to inform future
directions to improve long-term care.
Introduction
Stroke is a leading cause of death and disability worldwide with an estimated annual incidence of
16.9 million first strokes and 6 million stroke-related deaths (Krishnamurthi et al., 2013).
Although the age-specific incidence of stroke and transient ischaemic attack (TIA) has been
in decline globally, the number of people affected by these conditions has increased (Feigin
et al., 2017). Based on the Global Burden of Disease 2013 study, stroke is the third leading cause
of disability worldwide (Feigin et al., 2017). Furthermore, stroke and TIA patients are at high
risk of recurrent stroke (Mohan et al., 2011). The majority of risk factors for these conditions are
modifiable (Feigin et al., 2016).
Often, stroke and TIA survivors present with multimorbidity – having at least two or more
chronic conditions (Barnett et al., 2012; Wallace et al., 2015). Related to this, comorbidity refers
to co-existing conditions with an index condition of specific interest (van denAkker et al., 1996).
Although we pay particular attention to stroke/TIA as conditions of interest, for the purposes of
this paper we use the term multimorbidity, because stroke/TIA might not be the primary con-
dition of a patient and might present interdependently or independently of other conditions
(Barnett et al., 2012; Gallacher et al., 2014; Lefèvre et al., 2014).
Whilst multimorbidity is widely recognised for older adults with a stroke/TIA diagnosis, evi-
dence also shows that many people aged <50 years including stroke survivors (Maaijwee et al.,
2014) also experiencemultimorbidity (Barnett et al., 2012; Cassell et al., 2018). The development
of efficient and cost-effective care models to better serve this population remains high on policy
agendas (National Heart Stroke and Vascular Health Strategies Group (Australia), 2004;
Department of Health, 2007; U.S. Department of Health and Human Services, 2010; Centers
for Disease Control and Prevention, 2012; The Scottish Government, 2014; The Ministry of
Health and Care Services (Norway), 2015) and reinforced in the World Health Organization’s
(2013) Global Action Plan for the Prevention and Control of Noncommunicable Diseases.
Integrated care approaches to managing multimorbidity, often involving different health and
social care professionals, are encouraged particularly in primary healthcare, where the majority
of care is provided and needs are addressed (Roland et al., 2012; Kringos et al., 2015; Cassell
et al., 2018).
A better understanding of both stroke and TIA multimorbidity and current provisions for
managing these could inform the development of sustainable care models in the future. The role
of primary healthcare is important in this context, as re-emphasised by the 40th Anniversary of
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the Alma-Ata Declaration. In the draft Declaration 2.0 for 2018,
primary healthcare services ought to: offer comprehensive, well-
coordinated, long-term care that is people centred and responsive
to their context and needs (World Health Organization, 2018).
Therefore, this article aims to discuss the current literature onmul-
timorbidity in stroke/TIA and the contemporary challenges to
managing multimorbidity in relation to these conditions in
primary care, and argue the case for research into profiling multi-
morbidity in relation to stroke/TIA, and characterising integrated
care approaches for this population.
What is known about multimorbidity in stroke/TIA
Epidemiology
Multimorbidity is common in stroke and TIA (Tran et al., 2018;
The Academy ofMedical Sciences, 2018). Gallacher and colleagues
(2014) collated the evidence for multimorbidity in stroke across 40
conditions in Scotland and found that the overwhelming majority
(94.2%) of those with a stroke diagnosis in their GP records (n= 35
690) had one or more existing morbidities excluding stroke,
whereas, only 48% of the comparator group (ie, no stroke, n= 1
388 688) had one or more morbidities. The two most frequent
physical comorbidities for those with a diagnosis of stroke were
hypertension and coronary heart disease, consistent with other
studies (Barnett et al., 2012; Bergman et al., 2015; O’Donnell
et al., 2016).
A large-scale study of multimorbidity in cardiovascular disease
(ie, ischaemic heart disease, and stroke or TIA) across 56 condi-
tions found that of 4.2 million UK adults, 229 205 individuals expe-
rienced cardiovascular disease (Tran et al., 2018). Between 2000
and 2014, rates of multi- and comorbidity increased fourfold
(6.3–24.3%) for this population. However, this study did not report
the comorbidities associated with stroke/TIA specifically. Also in
the UK, Gallacher and colleagues (2018) found, in a sample of 8
751 stroke/TIA patients, patients with multimorbidity have
increased risk of mortality and this risk increases as the number
of comorbid conditions increases (regardless of type of condition).
Both studies found higher numbers of comorbidities in females,
older age groups, and people living in deprived areas (Gallacher
et al., 2018; Tran et al., 2018). Comorbid conditions are also
associated with poorer functional outcome post-stroke (Karatepe
et al., 2008). However, pairings or clusters of comorbid conditions
– types of co-occurring conditions – in relation to outcomes other
than mortality, such as quality of life, were not explored.
The differences between the temporal relationship (ie, pre-
stroke, post-stroke, unrelated) and timespan in which comorbid
conditions present in relation to stroke/TIA also need further
exploration given subsequent implications on treatment, care
management, and health service financing and planning
(Valderas et al., 2009). One study found an association between
stroke and subsequent increased risk of progression to heart dis-
ease and diabetes; however, the population was women only and
self-report data were used (Xu et al., 2018). A nuanced understand-
ing of cardiometabolic and non-cardiometabolic comorbidities
could help with developing strategies that better take these into
account.
Measures of multimorbidity
Measuring multimorbidity is challenging due to a lack of
international consensus regarding its conceptualisation, scope,
and how conditions are defined. Comparison of multimorbidity
prevalence rates across different populations and settings is
hindered by availability of data, the variety of measurement tools,
and the broad range of conditions included in existing multi-
morbidity measures (Fortin et al., 2012; Lefèvre et al., 2014).
A recent study concerning the key factors for consideration
when measuring multimorbidity concluded that there is ‘no single
“best” measure of multimorbidity (p. 6)’ (Griffith et al., 2018).
Broadly, multimorbidity measures are characterised as non-
weighted (ie, frequency counts of co-occurring diseases) or weighted
indices (ie, accounting for condition severity, healthcare utilisation)
(Huntley et al., 2012). The most commonly used multimorbidity
measures are disease counts, weighted measures particularly the
Charlson Comorbidity Index, the Cumulative Illness Rating Scale,
the Index of Coexistent Disease, and the Adjusted Clinical Groups
System (Johnston et al., 2019). However, in stroke epidemiology
research, frequency counts are most commonly used (Gallacher
et al., 2014; Lefèvre et al., 2014; Bergman et al., 2015; Gallacher
et al., 2018; Tran et al., 2018; Xu et al., 2018).
Whilst these indices are useful for a range of purposes (eg, clini-
cal, research, health services planning), some are decades old (Linn
et al., 1968; Charlson et al., 1987) and conditions included in these
measurement tools might not reflect the contemporary conditions
that are known to increase the risk ofmortality. Furthermore, some
measurement tools have been developed using a limited popula-
tion (Charlson et al., 1987). A recent expert panel study has iden-
tified that current multimorbidity measures do not account for
social determinants of health and mental health, and episodic con-
ditions (ie, recurring conditions or previous diagnoses that have
already been treated). Such factors are important to consider when
developing models of care and health policy (Griffith et al., 2018).
Therefore, a challenge for multimorbidity research is capturing the
complex nature of multimorbidity – going beyond physical diag-
noses – and ensuring that the appropriate measurement tools are a
good fit with the study purpose and/or stakeholder objectives.
Managing multimorbidity in relation to stroke/TIA
The evidence for increasing multimorbidity in stroke/TIA has
implications for treatment burden, including but not limited to
polypharmacy (Ostwald et al., 2006; Gallacher et al., 2014), health-
care utilisation (Cassell et al., 2018), and treatment adherence
(Mair and May, 2014; Tran et al., 2018). Importantly, there is evi-
dence demonstrating that variations in multimorbidity patterns
across different age groups (Tran et al., 2018) and socioeconomic
backgrounds (Bray et al., 2018; Gallacher et al., 2018) have pro-
found and wide-ranging impacts on people’s functioning, well-
being, and quality of life (Fortin et al., 2004; Navickas et al.,
2016). For example, people living in areas of deprivation tend to
have a first stroke earlier (Bray et al., 2018) and are at greater risk
of experiencing comorbidities (Barnett et al., 2012), when com-
pared to their more affluent peers.
Stroke is a leading cause of disability and many patients have
complex needs, including physical, emotional, social, communica-
tion, and cognition needs (Stroke Association, 2018). Post-stroke
care often requires complexmanagement plans to address patients’
rehabilitation, social care, and stroke prevention needs. Beyond the
array of impacts strokes/TIAs can have on individuals, their expe-
riences of primary healthcare present further challenges to service
delivery. A qualitative systematic review of patients’ experiences of
stroke management describes post-stroke ‘treatment burden’
which is intensified by poor communication and fragmented
healthcare (Gallacher et al., 2013). Additionally, a systematic
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review with meta-ethnography by Pindus and colleagues (2018)
showed that often stroke survivors and their carers felt marginal-
ised and abandoned due to the passivity of services. This passivity
was characterised by constraints to access to care, limited continu-
ity of care, poor communication between healthcare professionals
as well as between providers and stroke survivors and their carers,
and receiving varied information about stroke (Murray et al.,
2003). These are interacting factors that make caring for patients
with multimorbidity a challenge to healthcare providers and
systems (Mair and May, 2014).
Multimorbidity is likely to exacerbate this post-stroke treat-
ment burden through multiple uncoordinated appointments, pol-
ypharmacy, and lack of continuity of care (Noël et al., 2005).
Multimorbidity can also impact on patients’ rehabilitation and
recovery; for example, comorbid knee arthritis impairs patients’
ability to fully engage in stroke rehabilitation which can manifest
in frustration and required additional coping strategies (Wood
et al., 2009). Similarly, anxiety and depression have been found
to slow recovery from stroke (West et al., 2010). Stroke patients
with comorbidities are often excluded from rehabilitation clinical
trials (Nelson et al., 2017); therefore, evidence-based interventions
and recommendations might not be appropriate for the large
proportion of stroke patients with comorbidities.
Despite multimorbidity being commonplace, clinical guidelines
remain, by and large, disease specific and can be potentially harm-
ful to patients and burdensome for healthcare professionals (Boyd
and Fortin, 2010; Parekh and Barton, 2010; Guthrie et al., 2012).
Integrated care approaches for people with multimorbidity can
offer opportunities to treat conditions that have common manage-
ment strategies together (eg, hypertension and coronary heart dis-
ease, risk factors for stroke) including mental health comorbidities
that could co-occur with physical conditions. However, a recent
large-scale cluster-randomised controlled trial in GPs in England
and Scotland tested a 3D approach to care (ie, a patient-centred
way of managing dimensions of health, depression, and drugs) of
patients with multimorbidity found no improvements in health-
related quality of life. Nevertheless, the study found that such an
approach enhanced patient-centred care, including patient satisfac-
tion (Salisbury et al., 2018). To date, the evidence for integrated care
in primary care for people with multimorbidity is equivocal (Smith
et al., 2012; Salisbury et al., 2018) and requires further investigation
particularly in relation to stroke/TIA. Future studies testing complex
interventions such as that of Salisbury et al.’s (2018) should include
process evaluations, where feasible and cost effectiveness analysis if
the findings are positive (Ramsey et al., 2005; Moore et al., 2015).
Furthermore, an understanding of the temporal relationship
between conditions offers the opportunity for preventative interven-
tions, for example, to prevent the cluster of diabetes, heart disease,
and stroke (Xu et al., 2018).
Multimorbidity care practices vary and could be broadly classi-
fied into three groups: (i) those that are focussed on a specific disease
(ie, ‘index disease’) and include other conditions as comorbid; (ii)
those that are focussed on specific combinations of a number of
chronic diseases; and (iii) those that are not confined to specific
combinations of chronic diseases (Rijken et al., 2018). Moreover,
although interprofessional collaboration is a reported key feature
of integrated care models (Lalonde et al., 2012; Valentijn et al.,
2013), a multitude of terms are used interchangeably in integrated
care and interprofessional collaboration literature (Atwal and
Caldwell, 2002), making our understanding of how care pathways
and collaborative care practices are implemented in practice to
address multimorbidity in stroke/TIA a challenge. As such, the
range of approaches to managing multimorbidity in primary care
can also introduce gaps in care and service delivery, with knowledge
concerning best practices and health organisation remaining limited
(Rijken et al., 2018; The Academy of Medical Sciences, 2018). These
require illumination, as identifying markers of successful integrated
care and interprofessional collaboration can impact care and
professional practice.
Few randomised controlled trials have investigated the effec-
tiveness of interventions to enhance multimorbidity management;
nevertheless, the available literature has focussed on interventions
geared toward changes to the organisation of care or enhancing
interprofessional collaboration (Smith et al., 2012; Salisbury
et al., 2018). Given that stroke and TIA survivors frequently seek
medical support through primary care, it is imperative that current
practices, particularly in the context of multimorbidity, are better
understood. This is in line with the shift toward integrated care
models, which involve multiple healthcare professionals working
together to address multimorbidity, such as GPs, district or com-
munity nurses and pharmacists (Rijken et al., 2018). A particular
challenge is determining which of these integrated care approaches
are predominantly applied (including where and how), which are
most effective, and which are most acceptable to stroke/TIA
patients experiencing multimorbidity.
Going forward
Considering our current knowledge ofmultimorbidity in stroke/TIA
and how these are managed, we outline several suggestions for
advancing our understanding of these. First, a more detailed under-
standing of multimorbidity in stroke/TIA is needed. Specifically,
pairings and/or clusters of multimorbidity in stroke/TIA need to
be identified, and their relationships with and impact on clinical
and patient-reported outcomes assessed. Understanding the impact
of multimorbidity on stroke patients’ rehabilitation and recovery is
necessary to improve health and social care post-stroke.Measures of
multimorbidity and their burden are heterogeneous and thus have
implications on how associations and outcomes are investigated,
which need to be considered in relation to available data (Huntley
et al., 2012).
Studies of multimorbidity trends in stroke/TIA need to select
measures of multimorbidity based on study purpose and stake-
holder groups involved. Continuity of care, treatment burden,
and patients’ experience could potentially be improved by efficient
exchange of information between interdisciplinary healthcare pro-
viders, particularly specialists, GP, and the third sector. However,
multiple barriers for optimal communication exist, such as lack of
integration of electronic health records (Sadler et al., 2017). New
models of care are required to address poor communication
between healthcare providers to improve transition of care and fol-
low-up for stroke/TIA patients in the context of multimorbidity.
Importantly, multimorbidity trends in stroke/TIA need to be
explored in different contexts (eg, urban versus rural communities)
in different countries (ie, high-income versus low- and middle-
income), as well as different care settings (ie, primary care versus
secondary care) to contribute to the ‘global atlas’ of multimorbidity
(The Academy of Medical Sciences, 2018). Future research should
explore the settings in whichmultimorbidity in stroke/TIA is man-
aged. This needs to be better understood, especially in low- and
middle-income countries, as multimorbid conditions have impli-
cations on healthcare resources allocation and patient-centred care
(Valderas et al., 2009). Indeed, the vast majority of the multi-
morbidity literature is derived from high-income countries, despite
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most of non-communicable diseases occurring in low- andmiddle-
income countries (Xu et al., 2017). Specifically, the definitions,
components, provider profiles, and quality indicators of integrated
care approaches for stroke/TIA need to be better characterised.
The evidence base for multimorbidity management and risk fac-
tors need to be built alongside epidemiological evidence on multi-
morbidity in low- and middle-income countries, which is limited
(Xu et al., 2017). A further step would be to relate these integrated
care approaches to health outcomes (eg, quality of life) and assess
these approaches’ cost-effectiveness, which will require more pro-
spective, longitudinal research. Extensive research output from
high-income countries can inform future research in low- and
middle-income countries (Xu et al., 2017). For example, the influ-
ence of social determinants of health on multimorbidity rates in
these contexts should be explored. The burden of both communi-
cable diseases and non-communicable diseases on multimorbidity
should be assessed, particularly as communicable diseases remain a
challenge in many countries.
Concluding thoughts
The number of stroke and TIA survivors has been increasing, and
with this increase comes multiple challenges – including multi-
morbidity – to the healthcare system especially primary healthcare
services. A more considered understanding of the combinations of
diseases that co-occur with stroke/TIA in terms of how these vary
across different patient subgroups living in different contexts and
their associations with clinical and patient-reported outcomes
serve the important purpose of: (i) identifying their risk factors
for developing further morbidity, and/or experiencing another
stroke or TIA and (ii) developing context-appropriate strategies
for addressing wide-ranging and long-term needs, such as cogni-
tive impairment and rehabilitation. From this understanding, new
models of integrated care practices can be developed, informed by
evidence and current effective integrated care practices. The land-
mark Alma-Ata Declaration’s 40th anniversary brings to the spot-
light the need for high-quality, integrated primary healthcare in the
context of an ageing population and the rise of multimorbidity
globally. Patient-centred, individualised, and well-coordinated
care is required to optimise stroke recovery and reduce treatment
burden in relation to patients’ morbidities. There is a tension
within longer term stroke care as to the extent to which this is best
delivered by generalists and the extent to which it should be deliv-
ered by specialists. A more nuanced understanding of the epidemi-
ology of multimorbidity in stroke/TIA will help inform this debate.
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